5 67 Pill - white oval, 20mm
Pill with imprint 5 67 is White, Oval and has been identified as Metoprolol Succinate Extended-Release 200 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Metoprolol is used in the treatment of Angina; High Blood Pressure; Angina Pectoris Prophylaxis; Heart Failure; Heart Attack and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 5 67
Metoprolol Succinate Extended-Release
- Imprint
- 5 67
- Strength
- 200 mg
- Color
- White
- Size
- 20.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Cardioselective beta blockers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1341
- Inactive Ingredients
-
microcrystalline cellulose,
croscarmellose sodium,
ethylcellulose (10 mPa.s),
glycerin,
hypromelloses,
magnesium stearate,
methylcellulose (15 mPa.s),
polyethylene glycol,
povidone k30,
silicon dioxide,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "5 67"
More about metoprolol
- Check interactions
- Compare alternatives
- Reviews (642)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: cardioselective beta blockers
- Breastfeeding
- En español
Patient resources
- Metoprolol drug information
- Metoprolol (Intravenous) (Advanced Reading)
- Metoprolol (Oral) (Advanced Reading)
- Metoprolol Extended-Release Tablets
- Metoprolol Injection
Other brands
Professional resources
- Metoprolol monograph
- Metoprolol (FDA)
- Metoprolol Succinate (FDA)
- Metoprolol Succinate ER Capsules (FDA)
- Metoprolol Succinate ER Tablets (FDA)
Other brands
Lopressor, Toprol-XL, Kapspargo Sprinkle
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
